Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


Articles published in Neurosurg Clin N Am

Retrieve available abstracts of 19 articles:
HTML format
Text format



Single Articles


    January 2019
  1. MCKHANN GM, Duffau H
    Low-Grade Glioma: Epidemiology, Pathophysiology, Clinical Features, and Treatment.
    Neurosurg Clin N Am. 2019;30:xiii-xiv.
    PubMed     Text format    


  2. ROSSI M, Sani S, Nibali MC, Fornia L, et al
    Mapping in Low-Grade Glioma Surgery: Low- and High-Frequency Stimulation.
    Neurosurg Clin N Am. 2019;30:55-63.
    PubMed     Text format     Abstract available


  3. PALLUD J, McKhann GM
    Diffuse Low-Grade Glioma-Related Epilepsy.
    Neurosurg Clin N Am. 2019;30:43-54.
    PubMed     Text format     Abstract available


  4. SMITS A, Jakola AS
    Clinical Presentation, Natural History, and Prognosis of Diffuse Low-Grade Gliomas.
    Neurosurg Clin N Am. 2019;30:35-42.
    PubMed     Text format     Abstract available


  5. TORRES D, Canoll P
    Alterations in the Brain Microenvironment in Diffusely Infiltrating Low-Grade Glioma.
    Neurosurg Clin N Am. 2019;30:27-34.
    PubMed     Text format     Abstract available


  6. BREADY D, Placantonakis DG
    Molecular Pathogenesis of Low-Grade Glioma.
    Neurosurg Clin N Am. 2019;30:17-25.
    PubMed     Text format     Abstract available


  7. SANAI N
    How to Build a Neurosurgical Oncology Practice Specializing in Gliomas.
    Neurosurg Clin N Am. 2019;30:129-136.
    PubMed     Text format     Abstract available


  8. DUFFAU H
    Higher-Order Surgical Questions for Diffuse Low-Grade Gliomas: Supramaximal Resection, Neuroplasticity, and Screening.
    Neurosurg Clin N Am. 2019;30:119-128.
    PubMed     Text format     Abstract available


  9. WANG TJC, Mehta MP
    Low-Grade Glioma Radiotherapy Treatment and Trials.
    Neurosurg Clin N Am. 2019;30:111-118.
    PubMed     Text format     Abstract available


  10. DONOVAN LE, Lassman AB
    Chemotherapy Treatment and Trials in Low-Grade Gliomas.
    Neurosurg Clin N Am. 2019;30:103-109.
    PubMed     Text format     Abstract available


  11. CLARK VE, Cahill DP
    Extent of Resection Versus Molecular Classification: What Matters When?
    Neurosurg Clin N Am. 2019;30:95-101.
    PubMed     Text format     Abstract available


  12. HERVEY-JUMPER SL, Berger MS
    Evidence for Improving Outcome Through Extent of Resection.
    Neurosurg Clin N Am. 2019;30:85-93.
    PubMed     Text format     Abstract available


  13. HERBET G, Moritz-Gasser S
    Beyond Language: Mapping Cognition and Emotion.
    Neurosurg Clin N Am. 2019;30:75-83.
    PubMed     Text format     Abstract available


  14. HOLLON T, Stummer W, Orringer D, Suero Molina E, et al
    Surgical Adjuncts to Increase the Extent of Resection: Intraoperative MRI, Fluorescence, and Raman Histology.
    Neurosurg Clin N Am. 2019;30:65-74.
    PubMed     Text format     Abstract available


  15. BAUCHET L, Ostrom QT
    Epidemiology and Molecular Epidemiology.
    Neurosurg Clin N Am. 2019;30:1-16.
    PubMed     Text format     Abstract available


    October 2017
  16. SILVA D, Sharma M, Juthani R, Meola A, et al
    Magnetic Resonance Thermometry and Laser Interstitial Thermal Therapy for Brain Tumors.
    Neurosurg Clin N Am. 2017;28:525-533.
    PubMed     Text format     Abstract available


  17. KRIVOSHEYA D, Prabhu SS
    Combining Functional Studies with Intraoperative MRI in Glioma Surgery.
    Neurosurg Clin N Am. 2017;28:487-497.
    PubMed     Text format     Abstract available


    July 2017
  18. ROBIN AM, Lee I, Kalkanis SN
    Reoperation for Recurrent Glioblastoma Multiforme.
    Neurosurg Clin N Am. 2017;28:407-428.
    PubMed     Text format     Abstract available


  19. NOORANI I, Sanai N
    Surgical Management of Incidental Gliomas.
    Neurosurg Clin N Am. 2017;28:397-406.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: